Yassine Belloum
Hamburg, HH 20248, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Identification and characterization of tumor and stromal derived liquid biopsy analytes in pancreatic ductal adenocarcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 05, 2024
Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma.
Journal: EMBO molecular medicine
Published: September 12, 2023
Comparative evaluation of PD-L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non-small cell lung cancer patients.
Journal: Molecular oncology
Published: November 08, 2022
Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal Adenocarcinoma.
Journal: Clinical chemistry
Published: July 08, 2022
Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients.
Journal: Cancers
Published: July 07, 2022
Current and Future Clinical Applications of ctDNA in Immuno-Oncology.
Journal: Cancer research
Published: May 28, 2021
Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay.
Journal: Cells
Published: September 17, 2020
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond.
Journal: British journal of cancer
Published: November 12, 2019
Cancer-induced cardiac cachexia: Pathogenesis and impact of physical activity (Review).
Journal: Oncology reports
Published: September 22, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026